{
  "id": "western-blot",
  "title": "Western Blot",
  "lang": "en",
  "source_lang": "en",
  "summary": "Western blotting identifies specific proteins through electrophoretic separation, membrane transfer, and antibody-based detection, enabling analysis of protein abundance, size, and modification.",
  "category": "science",
  "subcategory": "biology",
  "type": "concept",
  "aliases": [
    "Western blotting",
    "protein immunoblotting",
    "immunoblotting"
  ],
  "generated_at": "2026-11-03",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/western-blot/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/western-blot/",
      "json": "https://aiwiki.page/zh/western-blot.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Western blotting is a laboratory technique used to detect a particular protein within a complex mixture. Proteins are separated, usually by gel electrophoresis, transferred to a membrane, and probed with an antibody that recognizes the target. The resulting pattern of bands provides information about the target’s presence, apparent molecular mass, and, under appropriately controlled conditions, relative abundance. Specialized assays can distinguish modified forms, cleavage products, or related protein variants.\n\nThe method combines physical separation with immunological recognition. This makes it more informative than a simple positive-or-negative binding assay: a signal can be evaluated against its position in the separation pattern. Western blotting is widely used in molecular biology, biochemistry, and biomedical research to investigate protein expression, signaling pathways, and experimental perturbations. Its reliability depends on sample preservation, separation and transfer efficiency, antibody specificity, and the quantitative behavior of the detection system."
    },
    {
      "heading": "Origins and analytical principles",
      "text": "Western blotting developed from the broader idea of transferring separated biological molecules from a gel onto a surface suitable for further analysis. In 1975, Edwin Southern described a method for detecting particular DNA sequences after electrophoresis and membrane transfer. This technique became known as the Southern blot. The later term Northern blot applied the same geographical wordplay to the analysis of RNA.\n\nProtein-transfer methods appeared in the late 1970s. In 1979, Jaime Renart, Jakob Reiser, and George Stark described transfer of proteins to diazobenzyloxymethyl paper for antibody-based detection. That year, Harry Towbin, Theophil Staehelin, and Julian Gordon published an electrophoretic transfer method using nitrocellulose membranes. Their approach established much of the practical framework of modern protein immunoblotting. W. Neal Burnette introduced the name “Western blotting” in a 1981 publication describing electrophoretic transfer and immunological detection of proteins. Unlike “Southern,” “Western” was not derived from a researcher’s surname.\n\nThe technique produces two distinct kinds of evidence. Electrophoretic migration supplies an estimate of apparent molecular mass, while antibody binding supplies evidence that a recognized molecular feature is present. The recognized feature, or epitope, may be a short amino-acid sequence, a folded surface, or a chemically modified region. Agreement between an expected migration position and antibody reactivity strengthens identification, but neither observation alone establishes identity. An unrelated protein may migrate at the same position and bind the same antibody.\n\nMost conventional Western blots use denaturing separation, which disrupts much of the protein’s native structure and dissociates many protein complexes. Consequently, the assay ordinarily measures individual polypeptide chains rather than intact functional assemblies. A protein’s abundance on a blot does not directly measure its enzymatic activity, cellular location, or interaction partners. Those properties require additional experimental designs or complementary techniques.\n\nThe method is often described as semiquantitative because signal intensity is influenced by several processes besides the amount of target. Extraction recovery, gel entry, transfer, membrane retention, antibody binding, and detector response can each vary among proteins and samples. Quantitative Western blotting is possible when these factors are characterized and the relevant signals remain within a validated response range. The visual simplicity of a band image therefore conceals an assay with multiple coupled sources of selectivity and measurement error."
    },
    {
      "heading": "Sample preparation and electrophoretic separation",
      "text": "Sample preparation determines which proteins reach the assay and which molecular states survive processing. Samples may originate from cultured cells, tissues, biological fluids, purified preparations, or subcellular fractions. Disruption releases proteins into a buffer whose detergent composition, salt concentration, and pH affect solubility and molecular stability. A buffer that efficiently extracts soluble cytoplasmic proteins may incompletely recover proteins embedded in the cell membrane or associated with insoluble structures. Thus, a blot generally represents the extractable fraction produced by a particular preparation, not necessarily every protein originally present.\n\nProteins can change during extraction. Proteolysis can generate fragments, while enzymes that remove chemical modifications can alter the state being measured. Cold processing and suitable inhibitors are commonly used to limit these changes. In assays of protein phosphorylation, phosphatase inhibition is especially important because phosphorylation may change rapidly after cell disruption. Conversely, some additives interfere with protein-concentration assays or subsequent electrophoresis. The measured sample concentration and the loaded amount therefore depend on the compatibility of the preparation and assay chemistry.\n\nThe most common separation method is sodium dodecyl sulfate–polyacrylamide gel electrophoresis, abbreviated SDS–PAGE. Sodium dodecyl sulfate is an anionic detergent that disrupts many noncovalent interactions and binds to polypeptides. Under typical conditions, many proteins acquire a broadly similar charge-to-mass ratio. Their migration through the polyacrylamide network then depends mainly on molecular size, with smaller polypeptides generally moving faster. Reducing agents such as dithiothreitol or β-mercaptoethanol break disulfide bonds, allowing disulfide-linked chains to separate.\n\nSample heating often promotes denaturation, but its effect is protein-dependent. Some highly hydrophobic or aggregation-prone proteins produce poorer patterns after strong heating. Nonreducing preparations preserve disulfide linkages, and nonheated preparations may retain some structural features. These differences can change migration and antibody recognition. Native electrophoresis, which omits strongly denaturing conditions, can preserve aspects of protein assembly, although migration then reflects charge and shape as well as size.\n\nGel composition determines the useful separation range. Higher acrylamide concentrations create smaller effective pores and improve resolution of smaller proteins; lower concentrations facilitate migration of larger proteins. Gradient gels contain a changing acrylamide concentration and accommodate a broader size range. In discontinuous buffer systems, a stacking region concentrates proteins into narrow zones before they enter the resolving gel. Excess sample, high salt, insoluble material, or excessive heating during electrophoresis can broaden or distort these zones.\n\nMolecular-mass markers provide reference bands, commonly labeled in kilodaltons. For many proteins within a gel’s useful range, the logarithm of molecular mass is approximately linear with relative migration distance. This permits interpolation rather than direct measurement of mass. Glycosylation, unusual detergent binding, incomplete reduction, and atypical sequence composition can produce anomalous migration. Prestained standards can also migrate differently from unstained standards because attached dyes alter their properties. A predicted sequence mass is therefore a guide to interpretation, not an exact specification of band position."
    },
    {
      "heading": "Transfer to a membrane",
      "text": "After separation, proteins are moved from the gel onto a membrane that preserves their relative positions and makes them accessible to detection reagents. In electrotransfer, an electric field is applied across a layered assembly containing the gel and membrane. Under standard SDS–PAGE conditions, detergent-coated proteins carry a net negative charge and migrate toward the positive electrode. Correct orientation places the membrane on the receiving side of the gel. Reversed orientation can move proteins away from the membrane.\n\nNitrocellulose and polyvinylidene difluoride, usually abbreviated PVDF, are the principal membrane materials. Both retain proteins through noncovalent interactions, including hydrophobic interactions. Nitrocellulose commonly provides low background but is comparatively fragile. PVDF is mechanically robust and often useful when membranes undergo repeated handling or reprobing. Conventional hydrophobic PVDF requires wetting with an appropriate alcohol before equilibration in aqueous buffer; some products are supplied in forms that simplify this step. Membrane chemistry also influences compatibility with fluorescence and total-protein stains.\n\nTransfer formats differ in the amount of buffer and arrangement of electrodes. Wet, or tank, transfer immerses the gel–membrane assembly in buffer and permits substantial heat dissipation, although temperature control may still be needed. Semidry transfer places the assembly between buffer-soaked sheets, while dry or rapid-transfer systems use specialized consumables and electrical programs. No format is universally optimal: performance depends on protein size, gel composition, membrane properties, and the chemistry of the transfer system.\n\nTransfer-buffer composition creates trade-offs. Methanol can promote removal of SDS and improve protein retention on some membranes, but it can also shrink gels and hinder transfer of large proteins. Small amounts of SDS may improve release of large or poorly soluble proteins from the gel while reducing membrane binding under some conditions. Prolonged or aggressive transfer can allow small proteins to pass through a membrane, particularly one with relatively large pores. Large proteins may instead remain partly trapped in the gel.\n\nPhysical contact is as important as buffer chemistry. Air bubbles interrupt the conducting pathway and create blank patches. Uneven pressure, damaged gels, and local heating can produce distorted or nonuniform patterns. Transfer efficiency may therefore differ across a single membrane and between molecular-mass regions. Successful transfer of a middle-sized marker does not establish that very large or very small targets were transferred efficiently.\n\nA reversible total-protein stain, such as Ponceau S, can reveal whether protein reached the membrane and whether lanes appear grossly comparable. Staining the residual gel provides complementary evidence about proteins that failed to transfer. Such checks distinguish an absent target signal from a failed transfer, although they do not establish equal recovery of every individual protein. Prestained markers are useful orientation aids but cannot substitute for examining the transferred sample itself."
    },
    {
      "heading": "Antibody recognition and immunochemical specificity",
      "text": "Following transfer, the membrane contains both immobilized sample proteins and unoccupied binding sites. A blocking step covers much of the unoccupied surface with proteins or other blocking agents, reducing nonspecific attachment of antibodies. Common blockers include nonfat milk and bovine serum albumin. Their effects are assay-dependent: milk contains casein and other constituents that can interfere with certain modification-specific antibodies or detection chemistries. Blocking is therefore part of the assay’s selectivity rather than a universally interchangeable preliminary step.\n\nThe primary antibody binds the intended target epitope. A monoclonal antibody recognizes a particular epitope and can provide relatively consistent specificity when produced from a stable source. A polyclonal antibody preparation contains antibodies against multiple epitopes. This can increase detection sensitivity or tolerance of partial epitope damage, but it can also increase cross-reactivity and introduce variation between preparations. Recombinant antibodies provide defined sequences and renewable production, although sequence definition alone does not demonstrate suitability for a particular assay.\n\nDenaturation changes which epitopes are accessible. An antibody that recognizes a folded protein in another assay may fail on a reducing Western blot because its epitope has been destroyed. Conversely, an epitope buried in the native structure may become accessible after SDS treatment. Antibody performance in immunohistochemistry, flow cytometry, or another binding assay does not automatically predict its performance on a blot. Even a Western-blot-validated antibody may behave differently across species, tissue types, or sample preparations.\n\nMost conventional assays use an unlabeled primary antibody followed by a labeled secondary antibody directed against the primary antibody’s host species and immunoglobulin class. For example, a rabbit primary antibody may be detected with an anti-rabbit immunoglobulin secondary. Several secondary antibodies can bind a primary antibody, amplifying the signal. Directly labeled primary antibodies eliminate the secondary step and can simplify multiplexing, but they may provide less amplification and require individual labeling or specialized reagents.\n\nCross-reactivity can arise at either antibody stage. A primary antibody may recognize a related protein or an unrelated sequence, while a secondary antibody may bind endogenous immunoglobulins in the sample. The latter is particularly relevant after immunoprecipitation, where immunoglobulin heavy and light chains often appear near approximately 50 and 25 kilodaltons under reducing conditions. These bands can obscure targets of similar apparent mass.\n\nWashing removes unbound and weakly retained antibodies. Detergent concentration, ionic strength, incubation time, and antibody concentration affect the balance between target signal and background. Stronger conditions do not necessarily improve specificity: they may eliminate a weak genuine interaction while leaving a strong off-target interaction. Specificity is ultimately established through experimental evidence, especially genetic controls and independent recognition reagents, rather than by the visual sharpness of a band."
    },
    {
      "heading": "Signal generation and image acquisition",
      "text": "The most widely used detection systems convert antibody binding into light emission or fluorescence. In enzyme-linked detection, the secondary antibody is commonly coupled to horseradish peroxidase or alkaline phosphatase. The enzyme acts on an added substrate to generate a detectable product. Because an enzyme can catalyze many reaction cycles, this arrangement amplifies the signal. Amplification increases sensitivity but also introduces dependence on substrate supply, reaction time, and local enzyme density.\n\nIn enhanced chemiluminescence, horseradish peroxidase catalyzes reactions involving luminol and peroxide that produce light. The light is recorded on photographic film or with a digital imaging system. Signal intensity changes after substrate addition, and different reagents have different emission kinetics. Two exposures of the same membrane are therefore not simply duplicate measurements unless timing and acquisition conditions are considered. At high target abundance, local substrate depletion or other reaction effects can cause distorted signals, including unusually pale centers within strong bands.\n\nFilm can detect weak chemiluminescent signals but has a limited and nonlinear useful response range. Once a region becomes saturated, greater protein abundance no longer produces a proportional increase in optical density. Digital detectors facilitate acquisition of multiple exposures and can identify pixels at the detector’s maximum recorded value. Nevertheless, a digital image without saturated pixels may still be outside the assay’s quantitative range because antibody binding or substrate chemistry may already have become nonlinear.\n\nFluorescence detection uses antibodies carrying fluorophores. Illumination at an appropriate wavelength excites the label, and an optical system records its emission at longer wavelengths. Visible and near-infrared systems are used. Fluorescence avoids the time-dependent enzymatic substrate reaction and can support a broad quantitative range, but its performance depends on fluorophore brightness, instrument response, membrane background, and sample autofluorescence. It is not automatically more sensitive or more linear under every experimental condition.\n\nMultiplex fluorescence distinguishes targets using spectrally different labels. This allows a target and a normalization signal, or a modified protein and its total form, to be measured on the same membrane. Suitable antibody combinations and secondary reagents are required to avoid cross-recognition. Spectral overlap, channel bleed-through, and large differences in target abundance can complicate interpretation. Signals in different channels are not directly comparable as absolute protein amounts without appropriate standards.\n\nChromogenic detection produces a visible colored precipitate on the membrane and can be convenient when specialized imaging equipment is unavailable. Radioisotopic labels, including labeled protein A, were important in early immunoblotting and remain part of the method’s historical development. Across detection types, sensitivity is target- and assay-dependent; there is no universal detection limit for a Western blot. Image acquisition records the final output of the entire workflow, so a sensitive camera cannot recover a protein lost during extraction or transfer."
    },
    {
      "heading": "Quantification and normalization",
      "text": "Quantitative analysis usually begins with the integrated signal in a defined band region after estimation of local background. A simplified response model is\n\n\\[S = kM + B,\\]\n\nwhere \\(S\\) is measured signal, \\(M\\) is the amount of target protein, \\(B\\) is background, and \\(k\\) combines the efficiencies of detection and preceding assay steps. This model applies only within a range where response is approximately linear. Outside that range, doubling target amount need not double the measured signal. The relevant range belongs to a particular target, antibody, detection method, exposure, and sample context.\n\nA dilution series is a direct way to examine response behavior. Serial amounts of a representative sample reveal whether the target signal and the proposed normalization signal change proportionally over the intended loading range. A strong band may already be saturated while a weaker target remains approximately linear. Using the saturated band as a denominator can create apparent biological changes or conceal real ones. Validation therefore concerns both numerator and denominator, not simply the target of interest.\n\nNormalization attempts to account for differences in loading, transfer, or other shared technical factors. Traditional loading controls include actin, tubulin, and glyceraldehyde-3-phosphate dehydrogenase. These proteins are often abundant, which makes them easy to detect but also prone to saturation. Their abundance is not invariant: differentiation, disease models, metabolic changes, and drug treatments can alter expression. A protein described as “housekeeping” is therefore not automatically a stable reference in every experiment.\n\nTotal-protein normalization uses the aggregate protein signal in a lane or defined molecular-mass region. This can reduce dependence on a single reference protein, provided the stain or imaging chemistry itself has a suitable response range. It also changes the meaning of the result: target abundance is expressed relative to total transferred protein, not necessarily per cell, tissue mass, or biological structure. If treatment changes cell size or total protein content, equal-protein loading and equal-cell loading address different questions.\n\nFor a normalized target signal, a common calculation is\n\n\\[R_i = \\frac{S_{T,i}-B_{T,i}}{S_{N,i}-B_{N,i}},\\]\n\nwhere \\(T\\) denotes the target, \\(N\\) the normalization signal, and \\(i\\) the sample. Relative abundance may then be expressed as \\(R_i\\) divided by a designated reference value. Such ratios inherit uncertainty from both measurements. For phosphorylation assays, dividing phospho-specific signal by total-target signal estimates relative modification status, but it does not establish absolute phosphorylation occupancy unless the antibody responses are independently calibrated.\n\nComparisons across separate membranes introduce additional variability. A shared reference sample can help connect batches, although it cannot correct every membrane-specific distortion. Absolute quantification requires standards of known amount and careful consideration of whether purified standards and sample-derived targets transfer and bind antibodies equivalently.\n\nBiological replication is distinct from repeated measurement of the same extract. Multiple lanes or exposures do not create independent biological samples. Statistical analysis must reflect the experimental unit and the pairing or grouping of samples. Reporting fold changes alone, without the underlying variation and number of independent samples, can obscure both technical instability and genuine biological heterogeneity."
    },
    {
      "heading": "Validation, controls, and reproducibility",
      "text": "A persuasive Western blot establishes that the detected band represents the intended target and that differences among samples are not artifacts. An expected apparent molecular mass is useful but insufficient because many proteins occupy the same size range. Stronger evidence comes from genetic perturbation. Loss of a band after deletion of the target gene supports specificity, especially when an appropriate rescue restores the signal. Some gene disruptions produce truncated products or leave alternative transcripts intact, so the molecular consequences of the perturbation still matter.\n\nReduced signal after RNA interference provides supporting evidence, but incomplete depletion and off-target effects complicate interpretation. Expression of a tagged target can establish a migration reference, although overexpression may change processing, localization, or aggregation. Agreement between antibodies recognizing different parts of the same protein is another useful line of evidence. Identification by mass spectrometry can provide an orthogonal check when a band or enriched protein preparation is accessible.\n\nPositive and negative controls answer different questions. A known positive sample tests whether the assay can detect the target under the chosen conditions. A biologically justified negative sample tests whether an observed signal depends on target presence. Omitting the primary antibody helps identify secondary-antibody or detection-reagent background, but it does not test whether the primary antibody binds an unrelated protein. Similarly, peptide competition demonstrates competition for antibody binding; it does not by itself prove that the competing cellular band is the intended protein.\n\nModification-specific antibodies require additional validation. For a phospho-specific antibody, phosphatase treatment can test whether recognition depends on phosphorylation. Mutation of the relevant residue may provide more site-specific evidence, although it can also change protein conformation or stability. An antibody against a cleavage-generated epitope must be distinguished from one that recognizes both precursor and product. These controls define what molecular state the signal actually reports.\n\nCommon artifacts provide clues but are not diagnoses by themselves. High background may reflect excessive antibody, inadequate blocking, incomplete washing, or detector settings. Smearing can result from sample degradation, overloading, aggregation, or poor separation. Curved bands may reflect uneven heating; sharp blank regions may indicate trapped air during transfer. Unexpected extra bands can represent authentic isoforms, fragments, or off-target recognition. Assigning a cause requires controls rather than appearance alone.\n\nReproducible reporting includes the sample source, extraction conditions, loaded amount, gel and transfer system, membrane type, antibody identity and dilution, detection chemistry, and quantification procedure. Antibody catalog identifiers, clone information, and lot information where relevant help distinguish reagents with similar names.\n\nUncropped images and molecular-mass references preserve evidence needed to evaluate band selection. Cropping can improve presentation, but it should not conceal contradictory bands or imply that separately acquired lanes were adjacent. Spliced lanes require clear indication, and image adjustments must not selectively alter experimental groups. Repeated probing after antibody stripping can also change antigen retention or leave residual signal, making probing order and stripping history relevant to interpretation."
    },
    {
      "heading": "Applications, variants, and relationships to other methods",
      "text": "Western blotting is widely used to connect genetic or biochemical interventions with changes at the protein level. An increase in messenger RNA does not necessarily produce a corresponding increase in protein because translation and degradation are separately regulated. Blots therefore complement nucleic-acid assays when evaluating gene expression, gene disruption, or recombinant protein production. They can also reveal size changes that suggest precursor processing, cleavage, or altered modification, although identifying the chemical cause usually requires additional experiments.\n\nCell-signaling research frequently uses antibodies that distinguish phosphorylated and total forms of a protein. Measurements at multiple time points can reveal rapid activation and subsequent attenuation. Interpretation depends on the particular site: phosphorylation may activate, inhibit, alter localization, or have context-dependent effects. A phospho-specific signal is not a universal proxy for activity. Similarly, detection of cleaved proteins associated with apoptosis can support evidence for pathway engagement, but no isolated band establishes every feature of a cell-death process.\n\nFractionation can extend the method beyond whole-cell extracts. Analysis of cytoplasmic, nuclear, membrane, or organelle-enriched fractions can test redistribution of a target. Marker proteins help assess contamination between fractions, while recovery and loading determine whether changes reflect redistribution or unequal extraction. Western blotting after immunoprecipitation can investigate associated proteins or enriched modifications. Such experiments require controls for nonspecific binding and do not necessarily establish direct physical contact between detected partners.\n\nClinical immunoblots sometimes reverse the usual analytical arrangement: separated microbial proteins serve as antigens, and antibodies in a patient specimen are the analytes. Historically, HIV Western blots were widely used as supplemental antibody tests. Many contemporary HIV laboratory algorithms instead use antigen–antibody screening, antibody differentiation assays, and nucleic-acid testing. Immunoblots also occur in certain other infectious-disease testing systems, including some Lyme disease algorithms. Their clinical meaning depends on the validated assay, prescribed interpretation criteria, disease stage, and surrounding testing strategy rather than the generic presence of bands.\n\nSeveral variants alter the separation or detection format. Two-dimensional immunoblotting separates proteins first by isoelectric point and then by size, allowing related molecular forms to occupy distinct spots. Far-Western blotting uses a protein probe to investigate binding partners rather than relying solely on antibody recognition of the target. Dot blots and slot blots place samples directly on a membrane without electrophoretic separation; they are simpler but lose the molecular-size evidence that distinguishes a conventional Western blot.\n\nAutomated capillary immunoassays miniaturize separation and immunodetection within capillaries, often reducing manual handling and sample consumption. Their outputs and validation requirements differ from those of membrane blots despite similar analytical goals.\n\nOther methods answer complementary questions. An enzyme-linked immunosorbent assay can provide efficient measurement across many samples but generally lacks electrophoretic size information. Flow cytometry measures distributions among individual cells, while immunohistochemistry preserves tissue location. Mass spectrometry can identify peptides and distinguish many modifications without requiring a target-specific antibody. Western blotting occupies a particular analytical niche in which antibody recognition, apparent molecular size, and examination of a limited set of targets are required together."
    }
  ],
  "links": [
    "protein",
    "gel-electrophoresis",
    "antibody",
    "molecular-biology",
    "biochemistry",
    "dna",
    "southern-blot",
    "rna",
    "epitope",
    "enzyme",
    "cell",
    "ph",
    "cell-membrane",
    "sds-page",
    "electric-field",
    "monoclonal-antibody",
    "immunohistochemistry",
    "flow-cytometry",
    "fluorescence",
    "gene",
    "mass-spectrometry",
    "messenger-rna",
    "gene-expression",
    "apoptosis",
    "elisa"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}